class=”sc-3778e872-0 cKDKQr”>
The Federal Competition Commission (Comco) waved goodbye to the acquisition of Swiss pharmacy chain Zur Rose by Migros. Competition authorities did not set any conditions for the agreement.
“We found no indication of a dominant position in the market,” Weko director Patrik Ducrey said when asked by the AWP news agency on Thursday. The aim of Migros’ health breakthrough is to accompany patients throughout the entire treatment chain.
Migros and Zur Rose announced the transaction in early February. Migros will pay approximately 360 million francs for the agreement. Meanwhile, Zur Rose wants to focus on her business in Germany. Medbase Group already belongs to Migros. (SDA/kae)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
